The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
Before founding his own company, he held various positions as business editor, fund advisor, portfolio manager and finally as CEO of a listed investment company. He also held several positions on the supervisory board.
He is passionate about analyzing a wide variety of business models and investigating new trends, especially in the areas of e-commerce, fintech, blockchain or artificial intelligence.
Commented by Stefan Feulner
Commented by Stefan Feulner on August 14th, 2023 | 07:00 CEST
Plug Power, dynaCERT, Varta - Optimistic about the future
Amid global efforts to meet climate targets, renewable energy has established itself as the centerpiece of the energy transition. Since the beginning of the decade, listed companies in this sector have felt a tailwind fueled by billions in subsidies from policymakers. But the current horizon is cloudy. Unexpected delays and deep red figures dominate the scene. Nevertheless, drastically lower market valuations could open the door to potential long-term returns for investors.
Read
Commented by Stefan Feulner on August 10th, 2023 | 08:30 CEST
Palantir, First Phosphate, E.ON - A decade of growth
The climate transition requires significant investments in energy infrastructure, which should benefit companies like the utility provider E.ON well beyond the current decade. Another beneficiary of this transformation are producers of the raw materials needed for the energy transition, for which demand already exceeds scarce supply in some areas.
Read
Commented by Stefan Feulner on August 9th, 2023 | 08:40 CEST
BYD, Defense Metals, Rheinmetall - Rare opportunities
In the race to meet climate targets, both politics and business are entering uncharted territory. The rapid departure from fossil fuels calls for alternative energy sources, increasing dependence on metallic raw materials, especially copper, cobalt, nickel and rare earth metals. But these essential resources, predominantly sourced from China, pose not only economic but also security challenges for the West, as they also play a key role in armaments.
Read
Commented by Stefan Feulner on August 8th, 2023 | 09:15 CEST
Powerful movement through the flood of figures - Siemens Energy, Almonty Industries, Nio
The second quarter number season is at its peak, and surprises on both sides promise high volatility. BioNTech, the vaccine manufacturer, was hit hard after the end of the COVID-19 pandemic. Siemens Gamesa's wind power business also negatively affected the parent company's balance sheet. There are currently plenty of opportunities in the market, especially for traders.
Read
Commented by Stefan Feulner on August 7th, 2023 | 07:25 CEST
Breakthroughs in the hydrogen sector - Nikola, First Hydrogen, Plug Power
Just last week, the German cabinet approved the update of the National Hydrogen Strategy from 2020, which is now being further developed to meet the increased level of ambition in climate protection and the new challenges in the energy market. Hydrogen is seen as the missing piece of the energy transition puzzle, and not just for Germany. Considerable progress has been made in the development of vehicles powered by hydrogen and fuel cells. At the same time, many innovative companies from this sector appear promising in the long term after the correction.
Read
Commented by Stefan Feulner on August 3rd, 2023 | 07:10 CEST
The strategy works - Nikola, Power Nickel, CENIT AG
In today's economy, long-term success and sustainable growth are not a matter of chance but the result of careful strategies and wise decisions by experienced directors and managers. Successful business leaders are characterized by a clear vision, long-term planning and focused implementation. Only in this way can a company grow and generate long-term returns for its shareholders.
Read
Commented by Stefan Feulner on August 2nd, 2023 | 09:15 CEST
Well positioned for the future - BioNTech, Defence Therapeutics, Sanofi
There is currently a lot of movement in the capital-intensive biotech sector. After second-tier companies, in particular, were hit hard by the effects of tighter monetary policy last year and at times traded below their cash levels, many are now considered hot takeover candidates thanks to their innovative technologies. The well-heeled pharma giants must act to avoid missing out on future blockbusters.
Read
Commented by Stefan Feulner on August 1st, 2023 | 09:00 CEST
Biogen, Cardiol Therapeutics, Evotec - The acquisition wave is rolling
The biotechnology industry has seen a significant increase in acquisitions and mergers in recent months. Large pharmaceutical companies are looking to expand their portfolios to provide innovative solutions for unmet medical needs. At the same time, despite an increase in value in recent months, acquisition targets are still attractively valued due to the sell-off over the past year.
Read
Commented by Stefan Feulner on July 31st, 2023 | 09:50 CEST
BASF, Cantourage Group, Palantir - Now the analysts speak out
Currently, it is high noon for the release of first-half 2023 earnings. Despite all the uncertainties regarding geopolitical and fiscal policy, the majority of companies surprised positively. As a result, the Dow Jones, DAX, Nasdaq and others were able to climb to new highs for the year. Analysts also see further upside potential for many companies, which could accelerate the rally in the coming weeks.
Read
Commented by Stefan Feulner on July 27th, 2023 | 06:50 CEST
RWE, Regenx Tech Corp., Varta - Under the spell of the numbers
The number season for the first half of 2023 is currently reaching its peak. Google parent Alphabet was able to beat analysts' expectations. In contrast, Deutsche Bank reported lower profits than expected. Due to weaker potash fertilizer prices, K+S AG had to lower its profit forecasts. In addition, there were further surprises that will likely affect future share prices.
Read